Article
In vitro suppression of K65R reverse transcriptase-mediated tenofovir- and adefovir-5'-diphosphate resistance conferred by the boranophosphonate derivatives.
Antimicrobial agents and chemotherapy - 1 Sept 2007
Frangeul Antoine, Barral Karine, Alvarez Karine, Canard Bruno
Abstract excerpt
9-[2-(Boranophosphonomethoxy)ethyl]adenine diphosphate (BH(3)-PMEApp) and (R)-9-[2-(boranophosphonomethoxy)propyl]adenine diphosphate (BH(3)-PMPApp), described here, represent the first nucleoside phosphonates modified on their alpha-phosphates that act as efficient substrates for the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT). These analogues were synthesized and evaluated for their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
